Kathryn J. Gregory, MBA, leads the identification, evaluation and negotiation of new business development opportunities including alliances, collaborations, mergers and acquisitions at Purdue Pharma L.P.Ms. Gregory has more than 20 years of biotechnology and pharmaceutical industry experience and comes to Purdue Pharma from Shire where she was responsible for business development transactions for the Neuroscience and Ophthalmology business units.  Ms. Gregory’s background includes international business development, mergers and acquisitions, licensing, marketing, strategic sourcing and procurement.  Prior to Shire, Ms. Gregory held various executive business development leadership positions at a variety of pharmaceutical and biotechnology companies, including PhaseBio Pharmaceuticals, Teva Pharmaceuticals, Neose Technologies, Cytel Corporation and Gensia Sicor Pharmaceuticals.  Ms. Gregory earned a Master’s of Business Administration degree from Pepperdine University and a Bachelor’s of Science degree from the University of California, Berkeley.